Molecular modeling (semi-empirical calculations) was performed using the AM1 force field using SPARTAN. 1 Cavitand 1 was synthesized according to literature procedures. 2 Distilled water was purchased from Arrowhead. Acetonitrile (CH 3 CN) was purchased from EMD.
Dicyclohexylcarbodiimide (DCC) was purchased from Lancaster. Methanol (MeOH) was purchased from Macron. 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) was purchased from Strem Chemicals. 2-aminoethyltrimethylammonium chloride hydrochloride was purchased from Sigma Aldrich. Gadolinium (III) hexahydrate, yttrium (III) hydrate, and choline chloride were purchased from Alfa Aesar. All chemicals were used as received.
Synthesis of ligand 4
Aqueous acetonitrile (50%, 10 mL) was added to 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA, 100 mg, 0.25 mmol), and 2-aminoethyltrimethylammonium chloride hydrochloride (43.5 mg, 0.25 mmol) and stirred at room temperature until fully dissolved (15 minutes). DCC (dicyclohexylcarbodiimide, 51 mg, 0.31 mmol) was dissolved in pyridine (2 mL) and added dropwise to the reaction mixture. The reaction was stirred for 2 days in a sealed flask at room temperature. Measured isotopic distribution matches calculated prediction. The reaction was stirred until the pH was constant for 1 hour (4 hour total reaction time). The solution was then adjusted to pH ~ 11 by the addition of NaOH (0.1 M aq) and the reaction was stirred for 20 minutes more, then filtered through a 0.45 µm syringe filter. The product was lyopholized to powder, then purified via reversed phase column chromatography (C18 silica, 0-5% MeOH:H 2 O) to yield Gd·DOTA as a white solid (10.2 mg, 31%). Product was dissolved in distilled water and the final gadolinium concentration was determined via ICP-MS. NMR for this compound cannot be recorded because this compound is paramagnetic.
Effect of cavitand on gadolinium complex 2a
2a (125 µl of a 1 mM solution) was added to six 0.5 dram glass vials, which were lyophilized to dryness. Cavitand 1 (5 mg, 3.6 µmol) was dissolved in 368 µL H 2 O. The cavitand solution (12.5 µL per equivalent of Gd) was added to each vial to make vials containing gadolinium complex 2a with 1, 2, 3, 4, 5, and 10 equivalents cavitand, respectively. An appropriate volume of water was added to each vial to bring the total volume of water to 125 µL. The solutions were then transferred to a 3 mm diameter coaxial NMR tube insert for T 1 measurements. T 1 relaxation rates were then acquired using Varian's inversion recovery sequence, with interpulse from 62.5 ms to 32 s, and T 1 times were tabulated by the native software. 
Effect of choline on masked complex
To 9 glass vials were distributed choline chloride (10 mM aq). These were lyopholized to dryness. A solution of complex 2a (0.5 mM) along with 4 equivalents of cavitand 1 (125 µL, 0.5 mM [Gd] ) was added to the vials, which were then transferred to a 3 mm diameter coaxial NMR tube insert for T 1 measurements. Data were recorded as above. 
